Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers

Status:
Recruiting

Trial end date:
2022-04-21

Target enrollment:

Participant gender:

This an open label study to assess the pharmacokinetics of CT1812 in normal healthy volunteers.

Phase 1

Cognition Therapeutics